in this issue
EnviroTech :: Regulatory
Merck & Co. to Settle Vioxx Claims
11:03 AM MST | November 20, 2007 | Chemical Week Editorial Staff
Merck & Co. agreed earlier this month to pay a total of $4.85 billion to 47,000 groups of plaintiffs to settle a class-action lawsuit related to Vioxx, Merck’s former blockbuster painkiller drug that was withdrawn from the market in 2004. Vioxx was withdrawn because of side-effects including heart attacks and strokes that resulted in a number of patient deaths. Merck says it will pay the settlement into a fund and that plaintiffs may petition to receive a portion of the amount. Plaintiff groups include patients who had been prescribed Vioxx, and the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee